Literature DB >> 20644536

Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells.

Jose M Polo1, Susanna Liu, Maria Eugenia Figueroa, Warakorn Kulalert, Sarah Eminli, Kah Yong Tan, Effie Apostolou, Matthias Stadtfeld, Yushan Li, Toshi Shioda, Sridaran Natesan, Amy J Wagers, Ari Melnick, Todd Evans, Konrad Hochedlinger.   

Abstract

Induced pluripotent stem cells (iPSCs) have been derived from various somatic cell populations through ectopic expression of defined factors. It remains unclear whether iPSCs generated from different cell types are molecularly and functionally similar. Here we show that iPSCs obtained from mouse fibroblasts, hematopoietic and myogenic cells exhibit distinct transcriptional and epigenetic patterns. Moreover, we demonstrate that cellular origin influences the in vitro differentiation potentials of iPSCs into embryoid bodies and different hematopoietic cell types. Notably, continuous passaging of iPSCs largely attenuates these differences. Our results suggest that early-passage iPSCs retain a transient epigenetic memory of their somatic cells of origin, which manifests as differential gene expression and altered differentiation capacity. These observations may influence ongoing attempts to use iPSCs for disease modeling and could also be exploited in potential therapeutic applications to enhance differentiation into desired cell lineages.

Entities:  

Mesh:

Year:  2010        PMID: 20644536      PMCID: PMC3148605          DOI: 10.1038/nbt.1667

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  43 in total

1.  Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.

Authors:  Sarah Eminli; Jochen Utikal; Katrin Arnold; Rudolf Jaenisch; Konrad Hochedlinger
Journal:  Stem Cells       Date:  2008-07-17       Impact factor: 6.277

2.  Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Authors:  Matthias Stadtfeld; Nimet Maherali; David T Breault; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-02-14       Impact factor: 24.633

3.  Oct4 distribution and level in mouse clones: consequences for pluripotency.

Authors:  Michele Boiani; Sigrid Eckardt; Hans R Schöler; K John McLaughlin
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

4.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

5.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

6.  Induced pluripotent stem cells from a spinal muscular atrophy patient.

Authors:  Allison D Ebert; Junying Yu; Ferrill F Rose; Virginia B Mattis; Christian L Lorson; James A Thomson; Clive N Svendsen
Journal:  Nature       Date:  2008-12-21       Impact factor: 49.962

7.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

8.  Role of the murine reprogramming factors in the induction of pluripotency.

Authors:  Rupa Sridharan; Jason Tchieu; Mike J Mason; Robin Yachechko; Edward Kuoy; Steve Horvath; Qing Zhou; Kathrin Plath
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

9.  Disease-specific induced pluripotent stem cells.

Authors:  In-Hyun Park; Natasha Arora; Hongguang Huo; Nimet Maherali; Tim Ahfeldt; Akiko Shimamura; M William Lensch; Chad Cowan; Konrad Hochedlinger; George Q Daley
Journal:  Cell       Date:  2008-08-07       Impact factor: 41.582

10.  Promotion of reprogramming to ground state pluripotency by signal inhibition.

Authors:  Jose Silva; Ornella Barrandon; Jennifer Nichols; Jitsutaro Kawaguchi; Thorold W Theunissen; Austin Smith
Journal:  PLoS Biol       Date:  2008-10-21       Impact factor: 8.029

View more
  552 in total

1.  Generation of functional hepatic cells from pluripotent stem cells.

Authors:  Songyan Han; Alice Bourdon; Wissam Hamou; Noelle Dziedzic; Orit Goldman; Valerie Gouon-Evans
Journal:  J Stem Cell Res Ther       Date:  2012-08-15

Review 2.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells.

Authors:  Gustavo Tiscornia; Erica Lorenzo Vivas; Juan Carlos Izpisúa Belmonte
Journal:  Nat Med       Date:  2011-12       Impact factor: 53.440

Review 4.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

5.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

6.  Ca2+ activated K channels-new tools to induce cardiac commitment from pluripotent stem cells in mice and men.

Authors:  Martin Müller; Marianne Stockmann; Daniela Malan; Anne Wolheim; Michael Tischendorf; Leonhard Linta; Sarah-Fee Katz; Qiong Lin; Stephan Latz; Cornelia Brunner; Anna M Wobus; Martin Zenke; Maria Wartenberg; Tobias M Boeckers; Götz von Wichert; Bernd K Fleischmann; Stefan Liebau; Alexander Kleger
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

7.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

8.  Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles.

Authors:  Kaifeng Shao; Carmen Koch; Manoj K Gupta; Qiong Lin; Michael Lenz; Stephanie Laufs; Bernd Denecke; Manfred Schmidt; Matthias Linke; Hans C Hennies; Jürgen Hescheler; Martin Zenke; Ulrich Zechner; Tomo Šarić; Wolfgang Wagner
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

9.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

Review 10.  Pluripotent stem cells in regenerative medicine: challenges and recent progress.

Authors:  Viviane Tabar; Lorenz Studer
Journal:  Nat Rev Genet       Date:  2014-02       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.